跳到正文
原文
Endpoints News 生物医药· Reynald Castaneda·· 24 天前AI 评分31

诺华考虑绕过欧洲政府支付方因MFN

Novartis considers bypassing European government payers due to MFN

AI 导读

诺华CEO Vas Narasimhan表示,欧洲私人市场或自费市场推出新药并非不可行,但未提及具体策略或数据支持。该表态出现在Endpoints News报道中,未涉及药物名称、试验阶段或监管动作细节。企业未明确说明MFN政策对药品定价或医保谈判的影响。

正文

No­var­tis CEO Vas Narasimhan said Tues­day that launch­ing new drugs in the pri­vate mar­ket or in a self-pay mar­ket in Eu­rope is not off the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news